BalmfordJBorlandRHammondD. (2011) Adherence to and reasons for premature discontinuation from stop-smoking medications: Data from the ITC Four-Country Survey. Nicotine Tob Res13: 94–102.
2.
FioreMCJaenCRBakerTB. (2008) Treating tobacco use and dependence: 2008 update. Report, US Department of Health and Human Services, USA.
3.
GasserPHolsteinDMichelY. (2014) Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. J Nerv Ment Dis202: 513–320.
4.
GrobCSDanforthALChopraGS. (2011) Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry68: 71–78.
5.
HallSMHumfleetGLMuñozRF. (2009) Extended treatment of older smokers. Addiction104: 1043–1052.
6.
HofmannA (2013) LSD: My Problem Child. Oxford: Oxford University Press.
7.
JohnsonMWGarcia-RomeuACosimanoMP. (2014) Pilot study of the 5-HT2aR agonist psilocybin in the treatment of tobacco addiction. J Psychopharmacol. DOI: 10.1177/0269881114548296.
8.
JohnsonMWRichardsWAGriffithsRR (2008) Human hallucinogen research: Guidelines for safety. J Psychopharmacol22: 603–620.
9.
KrebsTSJohansenPO (2012) Lysergic acid diethylamide (LSD) for alcoholism: Meta-analysis of randomized controlled trials. J Psychopharmacol26: 994–1002.
10.
KupferschmidtK (2014) High hopes. Science345: 18–23.
11.
MillerWR (2004) The phenomenon of quantum change. J Clin Psychol60: 453–460.
12.
National Institute on Drug Abuse (2001) Hallucinogens and dissociative drugs. Report, National Institute on Drug Abuse research report series, National Institute of Health (NIH) publication, volume 01–4209. Rockville, MD: National Institute on Drug Abuse.
13.
National Institute on Drug Abuse (2005) LSD NIDA infofacts. Report, National Institute on Drug Abuse. Rockville, MD: National Institute on Drug Abuse.
14.
NuttDJKingLANicholsDE (2013) Effects of Schedule I drug laws on neuroscience research and treatment innovation. Nat Rev Neurosci14: 577–585.
15.
SavageCMcCabeOL (1973) Residential psychedelic (LSD) therapy for the narcotic addict: A controlled study. Arch Gen Psychiatry28: 808–814.